Zobrazeno 1 - 10
of 71
pro vyhledávání: '"Zhu, VW"'
Publikováno v:
Lung Cancer: Targets and Therapy, Vol Volume 12, Pp 61-65 (2021)
Shannon S Zhang,1 Viola W Zhu1,2 1University of California, Irvine School of Medicine, Department of Medicine, Orange, CA, USA; 2Chao Family Comprehensive Cancer Center, Orange, CA, USACorrespondence: Viola W ZhuUniversity of California, Irvine Schoo
Externí odkaz:
https://doaj.org/article/5baf978ecbe94f9e9c65f45036a12bcd
Publikováno v:
Lung Cancer: Targets and Therapy, Vol Volume 11, Pp 13-18 (2020)
Viola W Zhu, 1,* Misako Nagasaka, 2, 3,* Takafumi Kubota, 4 Kunil Raval, 5 Natasha Robinette, 6 Octavio Armas, 7 Wajd Al-Holou, 8 Sai-Hong Ignatius Ou 1 1Chao Family Comprehensive Cancer Center, Division of Hematology/Oncology, Department of Medicine
Externí odkaz:
https://doaj.org/article/fa9af63c8eec466787c07f2923d66294
Publikováno v:
Lung Cancer: Targets and Therapy, Vol Volume 10, Pp 21-26 (2019)
Viola W Zhu,1 Alexa B Schrock,2 Siraj M Ali,2 Sai-Hong Ignatius Ou1 1Chao Family Comprehensive Cancer Center, Division of Hematology/Oncology, Department of Medicine, University of California, Irvine School of Medicine, Orange, CA, USA; 2Clinical Dev
Externí odkaz:
https://doaj.org/article/92497f75a8b94fb7b5a39d98c3997684
Publikováno v:
Lung Cancer: Targets and Therapy, Vol Volume 9, Pp 111-116 (2018)
Viola W Zhu,1 Alexa B Schrock,2 Thangavijayan Bosemani,3 Bryan S Benn,4 Siraj M Ali,2 Sai-Hong Ignatius Ou1 1Chao Family Comprehensive Cancer Center, Division of Hematology/Oncology, Department of Medicine, University of California, Irvine School of
Externí odkaz:
https://doaj.org/article/cf8d2154987d49228f29c29d9f614742
Autor:
Drilon, A, Duruisseaux, M, Han, JY, Ito, M, Falcon, C, Yang, SR, Murciano-Goroff, YR, Chen, HQ, Okada, M, Molina, MA, Wislez, M, Brun, P, Dupont, C, Branden, E, Rossi, G, Schrock, A, Ali, S, Gounant, V, Magne, F, Blum, TG, Schram, AM, Monnet, I, Shih, JY, Sabari, J, Perol, M, Zhu, VW, Nagasaka, M, Doebele, R, Camidge, DR, Arcila, M, Ou, SHI, Moro-Sibilot, D, Rosell, R, Muscarella, LA, Liu, SV, Cadranel, J
Publikováno v:
Journal of Clinical Oncology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
PURPOSE Although NRG1 fusions are oncogenic drivers across multiple tumor types including lung cancers, these are difficult to study because of their rarity. The global eNRGy1 registry was thus established to characterize NRG1 fusion-positive lung ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::c8d09b1ebe67fbd59c0f4fa20e000f5b
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=1806
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=1806
Autor:
Lin JJ; Massachusetts General Hospital Cancer Center, Boston, Massachusetts., Horan JC; Nuvalent, Inc., Cambridge, Massachusetts., Tangpeerachaikul A; Nuvalent, Inc., Cambridge, Massachusetts., Swalduz A; Centre Léon Bérard, Lyon, France., Valdivia A; Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain., Johnson ML; Sarah Cannon Research Institute, Nashville, Tennessee., Besse B; Paris-Saclay University, Gustave Roussy Cancer Center, Villejuif, France., Camidge DR; University of Colorado, Anschutz Medical Campus, Aurora, Colorado., Fujino T; Massachusetts General Hospital Cancer Center, Boston, Massachusetts., Yoda S; Massachusetts General Hospital Cancer Center, Boston, Massachusetts., Nguyen-Phuong L; Massachusetts General Hospital Cancer Center, Boston, Massachusetts., Mizuta H; Paris-Saclay University, Gustave Roussy Cancer Center, Villejuif, France., Bigot L; Paris-Saclay University, Gustave Roussy Cancer Center, Villejuif, France., Nobre C; Paris-Saclay University, Gustave Roussy Cancer Center, Villejuif, France., Lee JB; Yonsei University College of Medicine, Seoul, Republic of Korea., Yu MR; Yonsei University College of Medicine, Seoul, Republic of Korea., Mente S; Nuvalent, Inc., Cambridge, Massachusetts., Sun Y; Nuvalent, Inc., Cambridge, Massachusetts., Kohl NE; Kohl Consulting, Wellesley, Massachusetts., Porter JR; Nuvalent, Inc., Cambridge, Massachusetts., Shair MD; Nuvalent, Inc., Cambridge, Massachusetts., Zhu VW; Nuvalent, Inc., Cambridge, Massachusetts., Felip E; Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain., Cho BC; Yonsei University College of Medicine, Seoul, Republic of Korea., Friboulet L; Paris-Saclay University, Gustave Roussy Cancer Center, Villejuif, France., Hata AN; Massachusetts General Hospital Cancer Center, Boston, Massachusetts., Pelish HE; Nuvalent, Inc., Cambridge, Massachusetts., Drilon A; Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York.
Publikováno v:
Cancer discovery [Cancer Discov] 2024 Sep 13, pp. OF1-OF20. Date of Electronic Publication: 2024 Sep 13.
Autor:
Subbiah V; Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Hu MI; Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Mansfield AS; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA., Taylor MH; Developmental Cancer Therapeutics Laboratory, Earle A. Chiles Research Institute, Providence Portland Medical Center, Portland, Oregon, USA., Schuler M; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany., Zhu VW; Department of Medicine, University of California Irvine, Orange, California, USA., Hadoux J; Department of Endocrine Oncology, Gustave Roussy, Villejuif, France., Curigliano G; Clinical Division of Early Drug Development, European Institute of Oncology, IRCCS, Milano, Italy.; Department of Oncology and Hemato-Oncology, University of Milano, Milano, Italy., Wirth L; Center for Head and Neck Cancers, Massachusetts General Hospital, Boston, Massachusetts, USA., Gainor JF; Center for Head and Neck Cancers, Massachusetts General Hospital, Boston, Massachusetts, USA., Alonso G; Early Drug Development Unit, Vall d'Hebron University Hospital and Institute of Oncology, Barcelona, Spain., Adkins D; Division of Oncology, Washington University School of Medicine, St. Louis, Missouri, USA., Godbert Y; Nuclear Medicine and Thyroid Oncology Department, Bergonié Institute Cancer Center, Bordeaux, France., Ahn MJ; Department of Hematology and Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea., Cassier PA; Department of Medical Oncology, Centre Léon Bérard, Lyon, France., Cho BC; Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea., Lin CC; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan., Zalutskaya A; Blueprint Medicines Corporation, Cambridge, Massachusetts, USA., Barata T; F. Hoffmann-La Roche Ltd., Basel, Switzerland., Trask P; Genentech, Inc., South San Francisco, California, USA., Scalori A; F. Hoffmann-La Roche Ltd., Welwyn Garden City, United Kingdom., Bordogna W; F. Hoffmann-La Roche Ltd., Basel, Switzerland., Heinzmann S; F. Hoffmann-La Roche Ltd., Basel, Switzerland., Brose MS; Departments of Otorhinolaryngology; Head and Neck Surgery, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Publikováno v:
Thyroid : official journal of the American Thyroid Association [Thyroid] 2024 Jan; Vol. 34 (1), pp. 26-40.
Autor:
Benjamin DJ; Divsion of Hematology/Oncology, Department of Medicine, University of California Irvine, Irvine, California.; Present Address: 1 Hoag Drive, Building 51, Newport Beach, California., Chen S; Division of Biostatistics, Department of Public Health Sciences, University of California Davis, Davis, California., Eldredge JB; Division of Hematology and Oncology, Department of Medicine, University of California Davis School of Medicine, Sacramento, California., Schokrpur S; Division of Hematology-Oncology, Department of Medicine, University of California, San Diego School of Medicine, La Jolla, California., Li D; David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California., Quan Z; Division of Biostatistics, Department of Public Health Sciences, University of California Davis, Davis, California., Chan JW; Department of Radiation Oncology, University of California, San Francisco, San Francisco, California., Cummings AL; Division of Hematology Oncology, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California., Daly ME; Department of Radiation Oncology, University of California Davis School of Medicine, Sacramento, California., Goldman JW; Division of Hematology Oncology, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California., Gubens MA; Division of Hematology Oncology, Department of Medicine, University of California San Francisco, San Francisco, California., Harris JP; Department of Radiation Oncology, University of California Irvine, Irvine, California., Onaitis MW; Division of Hematology-Oncology, Department of Medicine, University of California, San Diego School of Medicine, La Jolla, California.; Division of Cardiothoracic Surgery, Department of Surgery, University of California, San Diego, La Jolla, California., Zhu VW; Divsion of Hematology/Oncology, Department of Medicine, University of California Irvine, Irvine, California.; Present Address: Nuvalent, 1 Broadway, 14th Floor, Cambridge, Massachusetts., Patel SP; Division of Hematology-Oncology, Department of Medicine, University of California, San Diego School of Medicine, La Jolla, California., Kelly K; Division of Hematology and Oncology, Department of Medicine, University of California Davis School of Medicine, Sacramento, California.; Present Address: 999, 17th Street, Suite 200, Denver, Colorado.
Publikováno v:
JTO clinical and research reports [JTO Clin Res Rep] 2022 Oct 29; Vol. 3 (12), pp. 100427. Date of Electronic Publication: 2022 Oct 29 (Print Publication: 2022).
Autor:
Wang M; Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 1 Shuaifuyuan, Dongcheng District, Beijing, China., Yang JC; National Taiwan University Hospital and National Taiwan University Cancer Center, Taipei, Taiwan., Mitchell PL; Austin Hospital, Heidelberg, Melbourne, Victoria, Australia., Fang J; Beijing Cancer Hospital, Beijing, China., Camidge DR; University of Colorado Hospital, Anschutz Cancer Pavilion, Aurora, Colorado., Nian W; Chongqing Cancer Hospital, Chongqing, China., Chiu CH; Taipei Veteran General Hospital, Taipei, Taiwan., Zhou J; Zhejiang University Affiliated Hospital, Zhejiang, China., Zhao Y; Affiliated Cancer Hospital of Zhengzhou University, Henan, China., Su WC; National Cheng Kung University Hospital, Tainan, Taiwan., Yang TY; Taichung Veteran Hospital, Taichung, Taiwan., Zhu VW; University of California Irvine Medical Center (UCIMC), Chao Family Comprehensive Cancer Center, Orange, California., Millward M; Linear Clinical Research Limited, Nedlands, Perth, Western Australia, Australia., Fan Y; Zhejiang Cancer Hospital, Zhejiang, China., Huang WT; Chi Mei Chest Hospital, Tainan, Taiwan., Cheng Y; Jilin Cancer Hospital, Jilin, China., Jiang L; Shanghai Chest Hospital, Shanghai, China., Brungs D; Southern Medical Day Care Centre, Wollongong, New South Wales, Australia., Bazhenova L; University of California, San Diego (UCSD), Moores Cancer Center, La Jolla, California., Lee CK; St George Hospital, Kogarah, Sydney, New South Wales, Australia., Gao B; Blacktown Hospital, Blacktown, Sydney, New South Wales, Australia., Xu Y; Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 1 Shuaifuyuan, Dongcheng District, Beijing, China., Hsu WH; National Taiwan University Hospital, Taipei, Taiwan., Zheng L; Dizal Pharmaceuticals, Shanghai, China., Jänne PA; Dana-Farber Cancer Institute, Boston, Massachusetts.
Publikováno v:
Cancer discovery [Cancer Discov] 2022 Jul 06; Vol. 12 (7), pp. 1676-1689.
Autor:
McCoach CE; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California; Present Address: Genentech, Inc., South San Francisco, California. Electronic address: caroline.mccoach@ucsf.edu., Rolfo C; Greenebaum Comprehensive Cancer Center, Experimental Therapeutics Program, School of Medicine, University of Maryland, Baltimore, Maryland; Present Address: Center for Thoracic Oncology at Tisch Cancer Institute, Mount Sinai Health System and Icahn School of Medicine at Mount Sinai, New York, New York., Drilon A; Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York., Lacouture M; Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York., Besse B; Department of Cancer Medicine, Gustave Roussy Cancer Campus, Villejuif, France., Goto K; Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa, Japan., Zhu VW; Department of Medicine, Division of Hematology and Oncology, University of California Irvine, Orange, California., Tan DSW; National Cancer Centre Singapore, Duke-National University of Singapore Medical School, Singapore., Farajian S; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California., Potter LA; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California; Present Address: Davis School of Medicine, University of California, Sacramento, Sacramento, California., Kherani JF; Loxo Oncology, Inc., a wholly owned subsidiary of Eli Lilly and Company, Stamford, Connecticut., Soldatenkova V; Eli Lilly and Company, Indianapolis, Indiana., Olek EA; Loxo Oncology, Inc., a wholly owned subsidiary of Eli Lilly and Company, Stamford, Connecticut., Muehlenbein CE; Eli Lilly and Company, Indianapolis, Indiana., Park K; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Publikováno v:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2022 Jun; Vol. 17 (6), pp. 768-778. Date of Electronic Publication: 2022 Feb 17.